Global Blood Plasma Market
市场规模（十亿美元）
CAGR :
% 
 Forecast Period |
2024 –2031 |
 Market Size (Base Year) |
USD 31.61 Billion |
 Market Size (Forecast Year) |
USD 70.77 Billion |
 CAGR |
% |
| Major Markets Players |
|
>全球血浆市场，按类型（高免疫球蛋白、白蛋白、因子 VIII、因子 IX、免疫球蛋白及其他）、输送方式（输液溶液、凝胶、喷雾剂、生物医学密封剂）、治疗指征（免疫学、肿瘤学、肺病学、风湿病学、移植、神经病学、血液学及其他）、应用（低丙种球蛋白血症、免疫缺陷疾病、血友病、血管性血友病 (vWD) 及其他）、最终用户（医院、诊所及其他）划分 - 行业趋势和预测到 2029 年。
全球血浆市场分析与洞察
已知血浆含有超过 100 种不同的蛋白质，例如纤维蛋白原、蛋白酶抑制剂、凝血因子、白蛋白和免疫球蛋白。它们在维持血压和交换矿物质（包括钾和钠）方面发挥着至关重要的作用。
- 2021 年全球血浆市场价值为 2584 万美元，预计到 2029 年将达到 6333 万美元，在 2022-2029 年预测期内的复合年增长率为 10.60%。由于慢性病和传染病的发病率上升，“医院”是各自市场中最突出的最终用户群体。DBMR 研究团队策划的市场报告包括深入的专家分析、患者流行病学、渠道分析、定价分析和监管框架。
全球血浆市场定义
血浆是指血液中呈淡黄色的透明液体成分，是蛋白质盐溶液。红细胞、白细胞和血小板是悬浮在血浆中的三种血细胞。血浆产品具有多种优势，包括血液凝固和防御等。
报告范围和市场细分
|
报告指标 |
细节 |
|
预测期 |
2022 至 2029 年 |
|
基准年 |
2021 |
|
历史岁月 |
2020（可定制至 2019 - 2014） |
|
定量单位 |
收入（百万美元）、销量（单位）、定价（美元） |
|
涵盖的领域 |
类型（高免疫球蛋白、白蛋白、因子 VIII、因子 IX、免疫球蛋白及其他）、给药方式（输液溶液、凝胶、喷雾剂、生物医学密封剂）、治疗适应症（免疫学、肿瘤学、肺病学、风湿病学、移植、神经病学、血液学及其他）、应用（低丙种球蛋白血症、免疫缺陷疾病、血友病、血管性血友病 (vWD) 及其他）、最终用户（医院、诊所及其他） |
|
覆盖国家 |
|
|
涵盖的市场参与者 |
Allergan (Ireland), AbbVie Inc. (US), GALDERMA (Switzerland), Evolus, Inc. (US), Revance (US), HUGEL, Inc. (South Korea), Ipsen Pharma (France), USWM, LLC. (US), Sun Pharmaceutical Industries Ltd. (India), Pfizer Inc. (US), GlaxoSmithKline plc (UK), Merz Pharma (Germany), Medytox (South Korea), Smith+Nephew (US), Sanofi (France), Novartis AG (Switzerland), Teva Pharmaceutical Industries Ltd. (Israel), LGM Pharma. (US), Lannett (US), NorthStar Rx LLC (US), and Par Pharmaceutical (US), among others |
|
Market Opportunities |
|
Global Blood Plasma Market Dynamics
This section deals with understanding the market drivers, opportunities, restraints and challenges. All of this is discussed in detail as below:
Drivers
-
Approval for Blood Plasma Products
The increase in number of approval for blood plasma products across the globe acts as one of the major factor driving the growth of blood plasma market. The rise in clinical studies for evaluating safety and efficiency of a wide range of therapeutic drugs have a positive impact on the market.
-
Prevalence of Blood Disorders
The rise in prevalence of blood and disorders, such as malignancies and leukemia and types of lymphoma, sickle-cell anemia and haemophilia, among others accelerate the market growth.
-
Increase In Mergers and Acquisitions
The increase in the number of mergers and acquisitions among manufacturers and research organizations to provide efficient medical care to patients and generate significant revenues by their sales options results in the expansion of the market.
Additionally, development in technology, large patient base and superior technology, increase in demand for effective therapies and surge in healthcare expenditure positively affect the blood plasma market.
Opportunities
Furthermore, research and development activities to develop advanced plasma derived product extends profitable opportunities to the market players in the forecast period of 2022 to 2029. Also, strategic manufacturing and distribution of plasma products will escalate the growth of blood plasma market.
Restraints/Challenges Global Blood Plasma Market
On the other hand, side effects caused due to use of blood plasma derivative such as dizziness, shortness in breath, allergic condition, dizziness and, fast heartbeats are expected to obstruct the market growth. The stringent regulatory policies for the approval are projected to challenge the blood plasma market in the forecast period of 2022-2029.
This blood plasma market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on blood plasma market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Patient Epidemiology Analysis
Death of more than 60,000 Americans anually have been reported due to hemorrhaging, or blood loss. Also, hemophilia A affects 1 in 5,000 male births each year in the U.S. according to the Centers for Disease Control and Prevention.
The blood plasma market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analyses of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.
COVID-19 Impact on Blood Plasma Market
The COVID-19 outbreak had a positive impact on growth of the blood plasma market. The COVID-19 pandemic stressed healthcare systems across the globe. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) for convalescent plasma for treating hospitalized patients with COVID-19 in August 2020. The antibodies or plasma are collected from individuals who have recovered from COVID-19 to use for the patients suffering from COVID-19.
Recent Development
- The European Blood Alliance (EBA) joined hands with the European Commission, consisting of DG CNECT, DG DIGIT and DG SANTE in May’2020. The partnership aims at building and managing an EU-wide, open-access platform that gathers data on the COVID-19 convalescent plasma therapy.
Global Blood Plasma Market
The blood plasma market is segmented on the basis of type, mode of delivery, therapeutic indication, application and end user. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- Hyperimmune Globulin
- Albumin
- Factor Viii
- Factor Ix
- Immunoglobulin
- Others
Based on type, the blood plasma market is segmented into hyperimmune globulin, albumin, factor viii, factor ix, immunoglobulin and others.
Mode of Delivery
- Infusion Solutions
- Gels
- Sprays
- Biomedical Sealants
On the basis of mode of delivery, the blood plasma market is segmented into infusion solutions, gels, sprays and biomedical sealants.
Therapeutic Indication
- Immunology
- Oncology
- Pulmonology
- Rheumatology
- Transplantation
- Neurology
- Hematology
- Other
Based upon therapeutic indication, the blood plasma market is segmented into immunology, oncology, pulmonology, rheumatology, transplantation, neurology, hematology and other.
Application
- Hypogammaglobulinemia
- Immunodeficiency Diseases
- Hemophilia
- Von Willebrand's Disease (Vwd)
- Others
On the basis of application, the blood plasma market is segmented into hypogammaglobulinemia, immunodeficiency diseases, hemophilia, von willebrand's disease (vWD) and others.
End User
- Hospitals
- Clinics
- Other
Blood plasma market has also been segmented based on the end user into hospitals, clinics and other.
Pipeline Analysis
Allergan, AbbVie Inc., GALDERMA, Evolus, Inc., Revance, HUGEL, Inc., Ipsen Pharma,USWM, LLC., Sun Pharmaceutical Industries Ltd., Pfizer Inc., GlaxoSmithKline plc, ., among others are some of the manufacturers involved with the development of plasma products.
Blood Plasma Market Regional Analysis/Insights
The blood plasma market is analysed and market size insights and trends are provided by country, type, mode of delivery, therapeutic indication, application and end user as referenced above.
The countries covered in the blood plasma market report are U.S., Canada and Mexico in North America, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa.
North America dominates the blood plasma market due to the rise in the inclination towards prophylaxis treatment within the region.
Asia-Pacific is expected to witness high growth during the forecast period of 2022 to 2029 because of the early diagnosis of the diseases in countries in the region.
The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Competitive Landscape and Blood Plasma Market Share Analysis
血浆市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对血浆市场的关注有关。
血浆市场的一些主要参与者包括
- 艾尔建（爱尔兰）
- AbbVie Inc.（美国）
- 高德美（瑞士）
- Evolus, Inc.（美国）
- Revance（美国）
- HUGEL, Inc.（韩国）
- 益普生制药（法国）
- USWM, LLC.（美国）
- 太阳制药工业有限公司 (印度)
- 辉瑞公司（美国）
- 葛兰素史克公司 (英国)
- Merz Pharma（德国）
- Medytox (韩国)
- Smith+Nephew（美国）
- 赛诺菲（法国）
- 诺华公司（瑞士）
- Teva Pharmaceutical Industries Ltd.（以色列）
- LGM Pharma.（美国）
- Lannett（美国）
- NorthStar Rx LLC（美国）
- Par Pharmaceutical（美国）
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
